Skip to main content
Fig. 5 | Journal of Experimental & Clinical Cancer Research

Fig. 5

From: ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling

Fig. 5

ASC-J9® can suppress tumor growth and metastasis via increasing ATF3 in mouse xenografts. a Anatomical pictures of intestinal/abdominal (left) and Metastasis statistics (right) show shATF3 treatment group have higher metastasis rates than Scr + Vehicle group and Scr + ASC-J9® group have lower rate than Scr + Vehicle group. b Representative IHC image (left) and quantification statistics (right) show ATF3 expression in mice xenograft, magnification, X100, X200. Data represent the mean ± SD, **p < 0.01, ns = not significant, by one-way ANOVA

Back to article page
\